Scienture Holdings, Inc. has announced a 1-for-25 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on October 5, 2026. The move was approved by the company's board of directors on September 17, 2026, and filed as an amendment to the company's Second Amended and Restated Certificate of Incorporation.
The reverse stock split is intended to help Scienture regain compliance with The Nasdaq Stock Market LLC’s continued listing rules, specifically the requirement that the minimum bid price of common stock be at least $1.00 per share. As of September 30, 2026, the company reported having 41,064,146 shares of common stock issued and outstanding. Following the split, the company expects approximately 1,642,565 shares to be issued and outstanding.
Under the terms of the split, every 25 shares held by a stockholder will be automatically converted into one issued and outstanding share. No fractional shares will be issued; instead, stockholders who would have received fractional shares will receive a cash payment in lieu of those shares. The par value per share and the total number of authorized shares remain unchanged. The trading symbol 'SCNX' will continue to be used, and the stock will begin trading on a split-adjusted basis when the market opens on October 5, 2026. The new CUSIP number for the stock following the split is 80880X203.
Proportional adjustments will also be made to the number of shares issuable upon the exercise or conversion of outstanding equity awards, convertible preferred stock, and warrants, as well as the applicable exercise or conversion prices.
